Alzheon Discovery of Anti-Oligomer Agent in Human Brain

Significance of breakthrough

  • Discovery of 3-SPA, endogenous protective agent in human brain with anti-Aβ oligomer activity
  • 3-SPA derived from ALZ-801
  • ALZ-801 enhances body’s natural defense against formation of toxic amyloid oligomers
  • Provides basis for favorable drug properties & safety of ALZ-801

Alzheon-new-discovery

Alzheon publications: Hey (2018) CNS Drugs ; Hey (2017) Clin Pharmacokinet; Kocis (2017) CNS Drugs